Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Callitas Health Inc MPHMF

Callitas Health Inc is a Canada-based company that is primarily engaged in integrated clinical-stage pharmaceutical development and over-the-counter (OTC) consumer goods marketing. The Company provides biomedical technologies and products. The Company offers drug treatments for obesity, infertility, intimacy issues, weight management, female sexual dysfunction solutions and women wellness.


GREY:MPHMF - Post by User

Bullboard Posts
Post by RedDeerMoneymanon Jul 12, 2017 12:03pm
94 Views
Post# 26460246

FACTS LIST

FACTS LISTThis is a long list, I'm going to keep it point form. You can look more in depth on your personal time.

M Pharma acquires rights to ORLISTAT a weight lost drug that had over $900 million in sales per year.
Sales started dropping drastically after various side effects, mainly explosive diarrhea.
M Pharma has developed a reformulated version of the drug with a three part capsule with charcoal to help the body better absorb, thus leading to the reversal of the side effects.
Also take note that ALL, M Pharma drugs are now PARABEN FREE a known cancer causing ingredient.
C-103 is slated for 2018, which will help drastically with obesity. Which in return help fight diabetes, heart disease and other related issues linked to obesity.

Aquisition of 40 J's, a private company owned and operated by the Thompson family, relatives of our fantastic CEO Gary Thompson. 
This included rights to ToConcieve and Extrinsa
Read the latest article on ToConcieve for all the great details.

Extrinsa is the next Ladies female sexual disfunction medicine coming in a gel formulation.
Almost 68% of woman can not achieve orgasm and the number climbs with age.
This gel formulation helps a woman with arousal, vaginal lubricantion and achieving orgasm.
Extrinsa is also set to be RELEASED shortly after ToConceive as the gel formulations are similar just less the part for sperm capasication which helps with the pregnancy part.

The Thompson family and friends control a HUGE amount of the stock and are building a VERY SOLID base for M Pharmaceutical as the 40 J's acquisition shows.

If anyone thinks this is a Pump and Dump, LOL sucks to be you.
This is a game changer for anyone getting in under fifty cents.

I've been following this company for two years, currently hold 4.9 million shares.
Gary is a great guy to talk to and has great passion towards woman's healthcare.

I suggest anyone serious about M Pharmaceutical's. Go like their Facebook Page they have really started focusing on updating it, along with TWO new video's with complete updates on C-103 and ToConceive.

Here's to a new flower that's coming into bloom.
??????? You ask, you'll see soon enough.

There's a lot more, but I got a bike trip to go on.

Cheers everyone, hope this helps.


Bullboard Posts